BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2019 12:23:27 PM | Browse: 790 | Download: 1363
 |
Received |
|
2019-05-21 01:52 |
|
Peer-Review Started |
|
2019-05-21 06:37 |
|
To Make the First Decision |
|
2019-06-10 08:05 |
|
Return for Revision |
|
2019-06-11 00:34 |
|
Revised |
|
2019-07-03 01:22 |
|
Second Decision |
|
2019-07-09 09:31 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-07-19 15:07 |
|
Articles in Press |
|
2019-07-19 15:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-08-28 06:21 |
|
Publish the Manuscript Online |
|
2019-08-28 12:23 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Chronic hepatitis delta: A state-of-the-art review and new therapies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Christy Gilman, Theo Heller and Christopher Koh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Christopher Koh, FAASLD, FACP, MD, Attending Doctor, Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, 10 Center Drive, Building 10, Room 9B-16, MSC 1800, Bethesda, MD 20892, United States. christopher.koh@nih.gov |
| Key Words |
Hepatitis delta; Epidemiology; Treatment; ; ; |
| Core Tip |
Delta hepatitis is a progressive disease affecting millions worldwide. Current treatment options are lacking. This review focuses on the history of interferon therapy, novel therapies that have been developed and future treatment options for a possible functional cure. |
| Publish Date |
2019-08-28 12:23 |
| Citation |
Gilman C, Heller T, Koh C. Chronic hepatitis delta: A state-of-the-art review and new therapies. World J Gastroenterol 2019; 25(32): 4580-4597 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i32/4580.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i32.4580 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
